Counter intuitively, patients carrying dominant GOF mutations in STAT1 suffer from chronic mucocutaneous candidiasis (CMC), which results from an impaired T-cell-mediated IL-17 immunity. This evidence concerns the gene STAT1 and Chronic mucocutaneous candidosis.